FDA Clearance Tracker · P080004-S030
IPure Preloaded IOL System
Last checked: Nov 20, 2026Latest source record: Apr 17, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Apr 17, 2020
Approved
Time to decision
123 days
Received Dec 16, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P080004-S030
- Device name
- IPure Preloaded IOL System
- Applicant
- Hoya Surgical Optics, Inc.
- Applicant location
- Chino Hills, CA
- Received
- Dec 16, 2019
- Decided
- Apr 17, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P080004
Device type
- Device type
- intraocular lens (HQL)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for packaging changes for the iSert® Preloaded System Platform Models 250 and 251. This device, as modified, will be marketed under the tradename IPure Preloaded System Platform Models B1PC and B1PY and is indicated for primary implantation in the capsular bag of the eye for the visual correction of aphakia in adult patients in whom a cataractous lens has been removed.
Source documents
Other decisions for Hoya Surgical Optics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.